Skip to main content
  • 3-Month vs. 12-Month DAPT: TARGET DAPT Study Finds Comparable Outcomes for PCI Patients With Firehawk Stent

    Short-term dual antiplatelet therapy (DAPT) for patients undergoing percutaneous coronary intervention (PCI) with the biodegradable-polymer rapamycin-eluting Firehawk stent is noninferior to extended-duration DAPT.  

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details